Spruce Biosciences (SPRB) Short Interest Ratio & Short Volume $0.08 +0.02 (+27.05%) As of 06/12/2025 03:49 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Spruce Biosciences Short Interest DataSpruce Biosciences (SPRB) has a short interest of 31,200 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a 72.38% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 716,746 shares to cover all short positions.Current Short Interest31,200 sharesPrevious Short Interest18,100 sharesChange Vs. Previous Month+72.38%Dollar Volume Sold Short$2.18 thousandShort Interest Ratio0.1 Days to CoverLast Record DateMay 31, 2025Outstanding Shares42,231,000 sharesShort Percent of Float0.08%Today's Trading Volume1,404,829 sharesAverage Trading Volume716,746 sharesToday's Volume Vs. Average196% Short Selling Spruce Biosciences? Sign up to receive the latest short interest report for Spruce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPRB Short Interest Over TimeSPRB Days to Cover Over TimeSPRB Percentage of Float Shorted Over Time Spruce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202531,200 shares $2.18 thousand +72.4%0.1%0.1 $0.07 5/15/202518,100 shares $1.19 thousand -95.9%N/A0 $0.07 4/30/2025437,200 shares $34.58 thousand -14.6%N/A0.1 $0.08 4/15/2025511,900 shares $67.57 thousand +275.3%1.4%0.5 $0.13 3/31/2025136,400 shares $39.57 thousand -48.7%0.4%0.4 $0.29 3/15/2025265,800 shares $89.07 thousand -37.5%0.7%0.7 $0.34 2/28/2025425,100 shares $165.36 thousand -5.0%1.1%0.7 $0.39 2/15/2025447,300 shares $181.38 thousand +81.4%1.2%0.8 $0.41 1/31/2025246,600 shares $92.48 thousand -44.6%N/A0.4 $0.38 1/15/2025444,900 shares $164.84 thousand +315.4%N/A0.8 $0.37 Get the Latest News and Ratings for SPRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024107,100 shares $44.98 thousand -51.1%N/A0.2 $0.42 12/15/2024219,000 shares $83.92 thousand +613.4%N/A0.4 $0.38 11/30/202430,700 shares $16.79 thousand -56.8%N/A0.1 $0.55 11/15/202471,000 shares $34.83 thousand -69.5%N/A0.2 $0.49 10/31/2024232,800 shares $123.66 thousand -18.4%N/A0.6 $0.53 10/15/2024285,200 shares $133.25 thousand -20.8%N/A0.7 $0.47 9/30/2024359,900 shares $170.92 thousand +44.5%N/A0.8 $0.47 9/15/2024249,000 shares $115.86 thousand -1.2%N/A0.6 $0.47 8/31/2024252,100 shares $117.15 thousand +22.7%N/A0.6 $0.46 8/15/2024205,400 shares $90.36 thousand +52.2%N/A0.4 $0.44 7/31/2024135,000 shares $69.80 thousand -23.6%N/A0.3 $0.52 7/15/2024176,800 shares $102.51 thousand -28.7%N/A0.4 $0.58 6/30/2024248,100 shares $128.44 thousand +103.9%N/A0.5 $0.52 6/15/2024121,700 shares $79.07 thousand +202.0%N/A0.2 $0.65 5/31/202440,300 shares $29.87 thousand -67.3%N/A0 $0.74 5/15/2024123,300 shares $98.64 thousand -42.8%N/A0.1 $0.80 4/30/2024215,500 shares $152.57 thousand +31.4%1.0%0.2 $0.71 4/15/2024164,000 shares $115.73 thousand -48.8%0.7%0.1 $0.71 3/31/2024320,400 shares $251.80 thousand +69.3%1.5%0.3 $0.79 3/15/2024189,300 shares $152.95 thousand +461.7%N/A0.2 $0.81 2/29/202433,700 shares $168.50 thousand -33.0%0.2%0.1 $5.00 2/15/202450,300 shares $254.52 thousand +17.3%0.3%0.2 $5.06 1/31/202442,900 shares $157.01 thousand +117.8%N/A0.2 $3.66 1/15/202419,700 shares $48.86 thousand -74.4%N/A0.1 $2.48 12/31/202377,000 shares $225.61 thousand +64.5%N/A0.4 $2.93 12/15/202346,800 shares $77.69 thousand -10.5%N/A0.3 $1.66 11/30/202352,300 shares $73.22 thousand -24.0%N/A0.4 $1.40 11/15/202368,800 shares $79.12 thousand +94.4%N/A0.6 $1.15 10/31/202335,400 shares $40.36 thousand +49.4%N/A0.4 $1.14 10/15/202323,700 shares $37.68 thousand -38.1%N/A0.3 $1.59The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again. 9/30/202338,300 shares $86.56 thousand -53.4%N/A0.5 $2.26 9/15/202382,100 shares $201.97 thousand +203.0%N/A1.1 $2.46 8/31/202327,100 shares $60.98 thousand -14.0%N/A0.4 $2.25 8/15/202331,500 shares $68.04 thousand -70.4%N/A0.3 $2.16 7/31/2023106,500 shares $239.63 thousand +31.5%N/A0.8 $2.25 7/15/202381,000 shares $167.67 thousand -16.3%N/A0.6 $2.07 6/30/202396,800 shares $208.12 thousand +497.5%N/A0.6 $2.15 6/15/202316,200 shares $38.23 thousand -96.6%N/A0.1 $2.36 5/31/2023470,900 shares $1.14 million -59.1%N/A2.9 $2.43 5/15/20231,150,000 shares $2.51 million -12.9%N/A6.6 $2.18 4/30/20231,320,000 shares $2.72 million -6.4%N/A7 $2.06 4/15/20231,410,000 shares $2.74 million +16.5%N/A6.5 $1.94 3/31/20231,210,000 shares $2.67 million +15.2%N/A2.6 $2.21 3/15/20231,050,000 shares $2.37 million -3.7%N/A0.7 $2.26 2/28/20231,090,000 shares $2.47 million +30.0%N/A0.7 $2.27 2/15/2023838,400 shares $2.29 million +1.6%13.6%0.6 $2.73 1/31/2023825,400 shares $2.43 million -31.8%6.8%0.6 $2.95 1/15/20231,210,000 shares $3.34 million +77.1%10.0%0.9 $2.76 12/30/2022683,100 shares $749.63 thousand +16.1%5.6%0.5 $1.10 12/15/2022588,600 shares $588.60 thousand +17.5%4.9%9.7 $1.00 11/30/2022500,900 shares $550.99 thousand +52.3%4.1%9.3 $1.10 11/15/2022328,900 shares $345.35 thousand +23.2%2.7%6.4 $1.05 10/31/2022267,000 shares $296.37 thousand +211.9%2.2%7.9 $1.11 10/15/202285,600 shares $97.58 thousand +40.1%0.7%2.6 $1.14 9/30/202261,100 shares $83.71 thousand -19.5%0.5%2.2 $1.37 9/15/202275,900 shares $132.83 thousand +22.0%0.6%1.7 $1.75 8/31/202262,200 shares $136.22 thousand -13.6%0.5%1 $2.19 8/15/202272,000 shares $154.80 thousand -31.8%0.6%0.5 $2.15 7/31/2022105,600 shares $195.36 thousand +16.3%0.9%0.7 $1.85 7/15/202290,800 shares $171.61 thousand -26.7%0.8%0.5 $1.89 6/30/2022123,900 shares $215.59 thousand -71.2%1.0%0.7 $1.74 6/15/2022429,700 shares $687.52 thousand +2.8%3.6%2.3 $1.60 5/31/2022417,900 shares $651.92 thousand +8.2%3.5%2.2 $1.56 5/15/2022386,200 shares $525.23 thousand -0.5%3.2%3.1 $1.36 4/30/2022388,300 shares $683.41 thousand +2.5%3.5%2.8 $1.76 4/15/2022378,700 shares $802.84 thousand +21.3%3.4%2.2 $2.12 3/31/2022312,100 shares $627.32 thousand -5.1%3.5%1 $2.01 3/15/2022328,700 shares $608.10 thousand -17.8%4.6%0.2 $1.85 2/28/2022399,900 shares $907.77 thousand -4.4%5.6%0.1 $2.27 2/15/2022418,300 shares $962.09 thousand -7.6%5.9%0.1 $2.30 1/31/2022452,600 shares $1.15 million -10.5%6.4%0.1 $2.54 1/15/2022505,400 shares $1.73 million -58.2%6.4%0.1 $3.43 12/31/20211,210,000 shares $5.40 million +78.7%17.1%0.3 $4.46 12/15/2021677,300 shares $1.69 million +28.4%9.6%0.2 $2.50 11/30/2021527,700 shares $1.36 million +10.8%7.5%3.9 $2.58 11/15/2021476,200 shares $2.09 million -0.7%6.8%4.4 $4.39 10/29/2021479,500 shares $2.28 million +2.0%6.8%7.7 $4.76 10/15/2021470,100 shares $2.11 million -3.0%6.0%9.6 $4.48 9/30/2021484,700 shares $2.91 million -10.5%6.2%11.2 $6.01 9/15/2021541,500 shares $3.91 million +1.3%7.0%10.3 $7.22Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 8/31/2021534,700 shares $4.10 million +0.6%6.9%8.7 $7.67 8/13/2021531,500 shares $4.08 million +9.3%6.9%8.9 $7.67 7/30/2021486,400 shares $4.48 million -1.6%6.3%6.9 $9.21 7/15/2021494,100 shares $4.91 million -3.1%6.4%6.1 $9.94 6/30/2021510,100 shares $5.72 million +5.6%6.6%6.4 $11.21 6/15/2021483,300 shares $5.62 million +6.5%6.2%6.8 $11.63 5/28/2021454,000 shares $6.42 million -1.9%5.9%6.4 $14.13 5/14/2021462,800 shares $6.76 million +3.2%6.4%6.7 $14.60 4/30/2021448,500 shares $7.83 million -4.6%6.2%7.9 $17.46 4/15/2021470,100 shares $7.46 million +9.9%6.5%9.6 $15.87 3/31/2021427,800 shares $6.51 million +9.1%5.9%9.5 $15.21 3/15/2021392,300 shares $10.12 million +0.7%5.4%5.9 $25.79 2/26/2021389,600 shares $8.26 million +3.3%5.4%6.2 $21.21 2/12/2021377,300 shares $8.05 million -1.4%5.2%5.8 $21.34 1/29/2021382,500 shares $7.68 million -3.8%6.2%5 $20.08 1/15/2021397,400 shares $9.41 million No Change6.4%4.7 $23.69 SPRB Short Interest - Frequently Asked Questions What is Spruce Biosciences' current short interest? Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 31,200 shares of SPRB short. 0.08% of Spruce Biosciences' shares are currently sold short. Learn More on Spruce Biosciences' current short interest. What is a good short interest percentage for Spruce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Spruce Biosciences' floating shares are currently sold short. Is Spruce Biosciences' short interest increasing or decreasing? Spruce Biosciences saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 31,200 shares, an increase of 72.4% from the previous total of 18,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Spruce Biosciences' short interest compare to its competitors? 0.08% of Spruce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Spruce Biosciences: Cyclerion Therapeutics, Inc. (1.32%), NLS Pharmaceutics Ltd. (6.89%), Kiora Pharmaceuticals, Inc. (0.60%), AEON Biopharma, Inc. (12.51%), Brainstorm Cell Therapeutics Inc. (8.70%), Carisma Therapeutics, Inc. (3.29%), Moleculin Biotech, Inc. (4.30%), Lakeshore Biopharma Co., Ltd. (0.12%), Traws Pharma, Inc. (2.12%), Biomerica, Inc. (2.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Spruce Biosciences stock? Short selling SPRB is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRB shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spruce Biosciences? A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRB, which in turn drives the price of the stock up even further. How often is Spruce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRB, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Cyclerion Therapeutics Short Interest Data NLS Pharmaceutics Short Interest Data Kiora Pharmaceuticals Short Interest Data AEON Biopharma Short Interest Data Brainstorm Cell Therapeutics Short Interest Data Carisma Therapeutics Short Interest Data Moleculin Biotech Short Interest Data Lakeshore Biopharma Short Interest Data Traws Pharma Short Interest Data Biomerica Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRB) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
